Radiologic and Pathologic Features of the Transmantle Sign in Focal Cortical Dysplasia: The T1 Signal Is Useful for Differentiating Subtypes

REFERENCES

1. 1.↵
   2. Colombo N,
   3. Tassi L,
   4. Deleo F, et al

   . Focal cortical dysplasia type IIa and IIb: MRI aspects in 118 cases proven by histopathology. Neuroradiology 2012;54:1065–77 doi:10.1007/s00234-012-1049-1 pmid:22695739

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Palmini A,
   3. Najm I,
   4. Avanzini G, et al

   . Terminology and classification of the cortical dysplasias. Neurology 2004;62(6 Suppl 3):S2–8 pmid:15037671

   Abstract/FREE Full Text
3. 3.↵
   2. Lerner JT,
   3. Salamon N,
   4. Hauptman JS, et al

   . Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009;50:1310–35 doi:10.1111/j.1528-1167.2008.01998.x pmid:19175385

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Colombo N,
   3. Salamon N,
   4. Raybaud C, et al

   . Imaging of malformations of cortical development. Epileptic Disord 2009;11:194–205 pmid:19720583

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Adler S,
   3. Lorio S,
   4. Jacques TS, et al

   . Towards in vivo focal cortical dysplasia phenotyping using quantitative MRI. Neuroimage Clin 2017;15:95–105 doi:10.1016/j.nicl.2017.04.017 pmid:28491496

   CrossRefPubMed
6. 6.↵
   2. Mühlebner A,
   3. Coras R,
   4. Kobow K, et al

   . Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol 2012;123:259–72 doi:10.1007/s00401-011-0920-1 pmid:22120580

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Kim DW,
   3. Kim S,
   4. Park SH, et al

   . Comparison of MRI features and surgical outcome among the subtypes of focal cortical dysplasia. Seizure 2012;21:789–94 doi:10.1016/j.seizure.2012.09.006 pmid:23040369

   CrossRefPubMed
8. 8.↵
   2. Kadom N,
   3. Trofimova A,
   4. Vezina GL

   . Utility of magnetization transfer T1 imaging in children with seizures. AJNR Am J Neuroradiol 2013;34:895–98 doi:10.3174/ajnr.A3396 pmid:23153867

   Abstract/FREE Full Text
9. 9.↵
   2. Blümcke I,
   3. Mühlebner A

   . Neuropathological work-up of focal cortical dysplasias using the new ILAE consensus classification system: practical guideline article invited by the Euro-CNS Research Committee. Clin Neuropathol 2011;30:164–77 doi:10.5414/NP300398 pmid:21726501

   CrossRefPubMed
10. 10.↵
    2. Urbach H,
    3. Scheffler B,
    4. Heinrichsmeier T, et al

    . Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 2002;43:33–40 pmid:11879384

    PubMedWeb of Science
11. 11.↵
    2. Wieser HG,
    3. Blume WT,
    4. Fish D, et al

    ; Commission on Neurosurgery of the International League Against Epilepsy (ILAE). ILAE Commission Report: proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 2001;42:282–86 pmid:11240604

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Leach JL,
    3. Greiner HM,
    4. Miles L, et al

    . Imaging spectrum of cortical dysplasia in children. Semin Roentgenol 2014;49:99–111 doi:10.1053/j.ro.2013.10.007 pmid:24342679

    CrossRefPubMed
13. 13.↵
    2. Abdijadid S,
    3. Mathern GW,
    4. Levine MS, et al

    . Basic mechanisms of epileptogenesis in pediatric cortical dysplasia. CNS Neurosci Ther 2015;21:92–103 doi:10.1111/cns.12345 pmid:25404064

    CrossRefPubMed
14. 14.↵
    2. Cepeda C,
    3. André VM,
    4. Vinters HV, et al

    . Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia? Epilepsia 2005;46:82–88 doi:10.1111/j.1528-1167.2005.01013.x pmid:15987258

    CrossRefPubMed
15. 15.↵
    2. Marusic P,
    3. Najm IM,
    4. Ying Z, et al

    . Focal cortical dysplasias in eloquent cortex: functional characteristics and correlation with MRI and histopathologic changes. Epilepsia 2002;43:27–32 pmid:11879383

    PubMedWeb of Science
16. 16.↵
    2. Gonzalez-Martinez JA,
    3. Ying Z,
    4. Prayson R, et al

    . Glutamate clearance mechanisms in resected cortical dysplasia. J Neurosurg 2011;114:1195–202 doi:10.3171/2010.10.JNS10715 pmid:21073256

    CrossRefPubMed
17. 17.↵
    2. Boonyapisit K,
    3. Najm I,
    4. Klem G, et al

    . Epileptogenicity of focal malformations due to abnormal cortical development: direct electrocorticographic-histopathologic correlations. Epilepsia 2003;44:69–76 pmid:12581232

    PubMedWeb of Science
18. 18.↵
    2. Mellerio C,
    3. Labeyrie MA,
    4. Chassoux F, et al

    . Optimizing MR imaging detection of type 2 focal cortical dysplasia: best criteria for clinical practice. AJNR Am J Neuroradiol 2012;33:1932–38 doi:10.3174/ajnr.A3081 pmid:22555587

    Abstract/FREE Full Text
19. 19.↵
    2. Eltze CM,
    3. Chong WK,
    4. Bhate S, et al

    . Taylor-type focal cortical dysplasia in infants: some MRI lesions almost disappear with maturation of myelination. Epilepsia 2005;46:1988–92 doi:10.1111/j.1528-1167.2005.00339.x pmid:16393166

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Yao K,
    3. Mei X,
    4. Liu X, et al

    . Clinical characteristics, pathological features and surgical outcomes of focal cortical dysplasia (FCD) type II: correlation with pathological subtypes. Neurol Sci 2014;35:1519–26 doi:10.1007/s10072-014-1782-9 pmid:24744193

    CrossRefPubMed
21. 21.↵
    2. Wang DD,
    3. Deans AE,
    4. Barkovich AJ, et al

    . Transmantle sign in focal cortical dysplasia: a unique radiological entity with excellent prognosis for seizure control. J Neurosurg 2013;118:337–44 doi:10.3171/2012.10.JNS12119 pmid:23216463

    CrossRefPubMed
22. 22.↵
    2. Berg AT,
    3. Vickrey BG,
    4. Langfitt JT, et al

    ; Multicenter Study of Epilepsy Surgery. The multicenter study of epilepsy surgery: recruitment and selection for surgery. Epilepsia 2003;44:1425–33 pmid:14636351

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Bien CG,
    3. Szinay M,
    4. Wagner J, et al

    . Characteristics and surgical outcomes of patients with refractory magnetic resonance imaging-negative epilepsies. Arch Neurol 2009;66:1491–99 doi:10.1001/archneurol.2009.283 pmid:20008653

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Rugg-Gunn FJ,
    3. Eriksson SH,
    4. Boulby PA, et al

    . Magnetization transfer imaging in focal epilepsy. Neurology 2003;60:1638–45 doi:10.1212/01.WNL.0000065891.93179.CC pmid:12771255

    Abstract/FREE Full Text
25. 25.↵
    2. Pinto Gama HP,
    3. da Rocha AJ,
    4. Braga FT, et al

    . Comparative analysis of MR sequences to detect structural brain lesions in tuberous sclerosis. Pediatr Radiol 2006;36:119–25 doi:10.1007/s00247-005-0033-x pmid:16283285

    CrossRefPubMed
26. 26.↵
    2. Girard N,
    3. Zimmerman RA,
    4. Schnur RE, et al

    . Magnetization transfer in the investigation of patients with tuberous sclerosis. Neuroradiology 1997;39:523–28 doi:10.1007/s002340050459 pmid:9258933

    CrossRefPubMed
27. 27.↵
    2. Kokkinos V,
    3. Kallifatidis A,
    4. Kapsalaki EZ, et al

    . Thin isotropic FLAIR MR images at 1.5T increase the yield of focal cortical dysplasia transmantle sign detection in frontal lobe epilepsy. Epilepsy Res 2017;132:1–7 doi:10.1016/j.eplepsyres.2017.02.018 pmid:28279892

    CrossRefPubMed
28. 28.↵
    2. Soares BP,
    3. Porter SG,
    4. Saindane AM, et al

    . Utility of double inversion recovery MRI in paediatric epilepsy. Br J Radiol 2016;89:20150325 doi:10.1259/bjr.20150325 pmid:26529229

    CrossRefPubMed
29. 29.↵
    2. Yagishita A,
    3. Arai N

    . Cortical tubers without other stigmata of tuberous sclerosis: imaging and pathological findings. Neuroradiology 1999;41:428–32 doi:10.1007/s002340050777 pmid:10426218

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Wolff SD,
    3. Balaban RS

    . Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989;10:135–44 doi:10.1002/mrm.1910100113 pmid:2547135

    CrossRefPubMedWeb of Science